BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790 AND Prognosis
9 results:

  • 1. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
    Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Functional tet2 gene polymorphisms increase the risk of neuroblastoma in Chinese children.
    Lin L; Wang B; Zhang X; Deng C; Zhou C; Zhu J; Wu H; He J
    IUBMB Life; 2024 Apr; 76(4):200-211. PubMed ID: 38014648
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
    Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
    Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing tet2 and deregulating 5hmC and 5mC DNA modifications.
    Lopez-Bertoni H; Johnson A; Rui Y; Lal B; Sall S; Malloy M; Coulter JB; Lugo-Fagundo M; Shudir S; Khela H; Caputo C; Green JJ; Laterra J
    Signal Transduct Target Ther; 2022 Feb; 7(1):37. PubMed ID: 35136034
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ten-eleven translocation protein 1 modulates medulloblastoma progression.
    Kim H; Kang Y; Li Y; Chen L; Lin L; Johnson ND; Zhu D; Robinson MH; McSwain L; Barwick BG; Yuan X; Liao X; Zhao J; Zhang Z; Shu Q; Chen J; Allen EG; Kenney AM; Castellino RC; Van Meir EG; Conneely KN; Vertino PM; Jin P; Li J
    Genome Biol; 2021 Apr; 22(1):125. PubMed ID: 33926529
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression and prognostic characteristics of m
    Li X; Meng Y
    J Cell Mol Med; 2021 Feb; 25(3):1383-1393. PubMed ID: 33400376
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. tet2 promotor methylation and tet2 protein expression in pediatric posterior fossa ependymoma.
    Pierscianek D; Teuber-Hanselmann S; Ahmadipour Y; Darkwah Oppong M; Unteroberdörster M; Müller O; Jabbarli R; Sure U; Zhu Y; El Hindy N
    Neuropathology; 2020 Apr; 40(2):138-143. PubMed ID: 31777116
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
    Fukunaga T; Fujita Y; Kishima H; Yamashita T
    PLoS One; 2018; 13(11):e0206552. PubMed ID: 30388142
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.